116
Views
1
CrossRef citations to date
0
Altmetric
OPEN PEER COMMENTARIES

Decisions on Innovation or Research for Devastating Disease

Pages 28-31 | Published online: 22 Nov 2021
 
This article refers to:
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?
This article is referred to by:
From “Ought” to “Is”: Surfacing Values in Patient and Family Advocacy in Rare Diseases

DISCLOSURE STATEMENT

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This publication was supported in part by grant 5R18HS026158-03 through the Agency for Healthcare Research and Quality.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 137.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.